Cargando…

Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications

Current standard-of-care (SOC) therapy for breast cancer includes targeted therapies such as endocrine therapy for estrogen receptor-alpha (ERα) positive; anti-HER2 monoclonal antibodies for human epidermal growth factor receptor-2 (HER2)-enriched; and general chemotherapy for triple negative breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Nishant, Das, Gokul M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406734/
https://www.ncbi.nlm.nih.gov/pubmed/30691108
http://dx.doi.org/10.3390/cells8020089

Ejemplares similares